Logo 6 a1e69dad97a22b9caa5aa6c606f6ea7f9e9b8c4d0352141ae8a7e9bed5512ee3
  • Antibodies
  • Assays/Kits
  • Proteins/Peptides
  • siRNAs/Functional Genomics
  • Biochemicals
  • cDNA Clones
  • Cell/Tissue/Blood Products
  • Genes
  • Images

GDC 0879

Name GDC 0879
Supplier R&D Systems
Catalog 4453
Prices $225.00, $925.00
Sizes 10 mg, 50 mg
Cas Number 905281-76-7
Chemical Name (E)-2,3-Dihydro-5-[1-(2-hydroxyethyl)-3-(4-pyridinyl)-1H-pyrazol-4-yl]-1H-inden-1-oneoxime
Formula C19H18N4O2
Molecular Weight 334.37
Purity >98%
Supplier Page Shop

Product References

Pharmacodynamics of - Pharmacodynamics of

Wong H, Belvin M, Herter S, Hoeflich KP, Murray LJ, Wong L, Choo EF. J Pharmacol Exp Ther. 2009 Apr;329(1):360-7.

RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance - RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance

Hatzivassiliou G, Song K, Yen I, Brandhuber BJ, Anderson DJ, Alvarado R, Ludlam MJ, Stokoe D, Gloor SL, Vigers G, Morales T, Aliagas I, Liu B, Sideris S, Hoeflich KP, Jaiswal BS, Seshagiri S, Koeppen H, Belvin M, Friedman LS, Malek S. Nature. 2010 Mar 18;464(7287):431-5.

Antitumor efficacy of the novel RAF inhibitor GDC-0879 is predicted by BRAFV600E - Antitumor efficacy of the novel RAF inhibitor GDC-0879 is predicted by BRAFV600E

Hoeflich KP, Herter S, Tien J, Wong L, Berry L, Chan J, O'Brien C, Modrusan Z, Seshagiri S, Lackner M, Stern H, Choo E, Murray L, Friedman LS, Belvin M. Cancer Res. 2009 Apr 1;69(7):3042-51.



Privacy
Terms
About us
Contact us

Copyright© 2025. All Rights Reserved